A Phase I Study of Lenalidomide and Ibrutinib in Combination with Rituximab

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Georgetown

Protocol Number
Georgetown 2013-1342 (NCI 9540)

To Learn More Call
201-510-0910